RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Musiliyu Musa to Cell Cycle

This is a "connection" page, showing publications Musiliyu Musa has written about Cell Cycle.
Connection Strength

0.496
  1. Musa MA, Joseph MY, Latinwo LM, Badisa V, Cooperwood JS. In vitro evaluation of 3-arylcoumarin derivatives in A549 cell line. Anticancer Res. 2015 Feb; 35(2):653-9.
    View in: PubMed
    Score: 0.111
  2. Musa MA, Latinwo LM, Virgile C, Badisa VL, Gbadebo AJ. Synthesis and in vitro evaluation of 3-(4-nitrophenyl)coumarin derivatives in tumor cell lines. Bioorg Chem. 2015 Feb; 58:96-103.
    View in: PubMed
    Score: 0.110
  3. Musa MA, Badisa VL, Latinwo LM. Cytotoxic activity of N, N'-Bis (2-hydroxybenzyl) ethylenediamine derivatives in human cancer cell lines. Anticancer Res. 2014 Apr; 34(4):1601-7.
    View in: PubMed
    Score: 0.105
  4. Musa MA, Badisa VL, Latinwo LM, Cooperwood J, Sinclair A, Abdullah A. Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines. Anticancer Res. 2011 Jun; 31(6):2017-22.
    View in: PubMed
    Score: 0.086
  5. Musa MA, Badisa VL, Latinwo LM, Waryoba C, Ugochukwu N. In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines. Anticancer Res. 2010 Nov; 30(11):4613-7.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support